RLAY
Relay Therapeutics Inc

1,165
Mkt Cap
$1.77B
Volume
3.82M
52W High
$11.49
52W Low
$1.78
PE Ratio
-6.14
RLAY Fundamentals
Price
$9.91
Prev Close
$10.00
Open
$10.26
50D MA
$8.91
Beta
1.87
Avg. Volume
2.45M
EPS (Annual)
-$1.61
P/B
3.04
Rev/Employee
$79,973.96
$929.56
Loading...
Loading...
News
all
press releases
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.
Key PointsNextech Invest increased its stake in Relay Therapeutics by 855,097 shares; the estimated trade value was ~$6.1 million based on average quarterly pricing...
Nasdaq News: Markets·2d ago
News Placeholder
More News
News Placeholder
Citizens Jmp Issues Positive Forecast for Relay Therapeutics (NASDAQ:RLAY) Stock Price
Citizens Jmp upped their target price on shares of Relay Therapeutics from $15.00 to $17.00 and gave the stock a "market outperform" rating in a research report on Tuesday...
MarketBeat·4d ago
News Placeholder
Wells Fargo & Company Boosts Relay Therapeutics (NASDAQ:RLAY) Price Target to $17.00
Wells Fargo & Company boosted their price target on shares of Relay Therapeutics from $15.00 to $17.00 and gave the stock an "overweight" rating in a research report on Tuesday...
MarketBeat·4d ago
News Placeholder
Relay Therapeutics Sees Unusually Large Options Volume (NASDAQ:RLAY)
Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) was the target of some unusual options trading activity on Monday. Stock investors purchased 5,148 call options on the company. This...
MarketBeat·5d ago
News Placeholder
Relay Therapeutics' Cancer Drug Hits 11.1-Month Progression Free Survival - What Does This Means For Pretreated Breast Cancer Patients?
Relay Therapeutics shares rise after Phase 3 data show zovegalisib achieved 11.1-month PFS in metastatic breast cancer patients.read more...
Benzinga·5d ago
News Placeholder
Commodore Capital LP Raises Stake in Relay Therapeutics, Inc. $RLAY
Commodore Capital LP lifted its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY - Free Report) by 27.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm...
MarketBeat·7d ago
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) Reaches New 1-Year High After Analyst Upgrade
Relay Therapeutics (NASDAQ:RLAY) Reaches New 12-Month High After Analyst Upgrade...
MarketBeat·8d ago
News Placeholder
Guggenheim Issues Positive Forecast for Relay Therapeutics (NASDAQ:RLAY) Stock Price
Guggenheim upped their price target on Relay Therapeutics from $15.00 to $22.00 and gave the stock a "buy" rating in a research note on Friday...
MarketBeat·8d ago
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) Sees Unusually-High Trading Volume - What's Next?
Relay Therapeutics (NASDAQ:RLAY) Sees Unusually-High Trading Volume - Should You Buy...
MarketBeat·10d ago
News Placeholder
Relay Therapeutics (RLAY) Soars 5.4%: Is Further Upside Left in the Stock?
Relay Therapeutics (RLAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·11d ago
<
1
2
...
>

Latest RLAY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.